6778
D. V. Jarikote et al. / Tetrahedron Letters 51 (2010) 6776–6778
5. (a) Lepore, S. D.; He, Y. J. Org. Chem. 2003, 68, 8261–8263; (b) Jarikote, D. V.;
Deshmukh, R. R.; Rajagopal, R.; Lahoti, R. J.; Daniel, T.; Srinivasan, K. V. Ultrason.
Sonochem. 2003, 10, 45–48; (c) Chen, M.-Y.; Lu, K.-C.; Lee, A. S.-Y.; Lin, C.-C.
Tetrahedron Lett. 2002, 43, 2777–2780; (d) Adewuyi, Y. G. Ind. Eng. Chem. Res.
2001, 40, 4681–4715; (e) Kardos, N.; Luche, J. L. Carbohydr. Res. 2001, 332, 115–
131; (f) Gholap, A. R.; Venkatesan, K.; Daniel, T.; Lahoti, R. J.; Srinivasan, K. V.
Green Chem. 2003, 5, 693–696.
6. Deng, S.; Gangadharmath, U.; Chang, C.-W. T. J. Org. Chem. 2006, 71, 5179–
5185.
7. Zhang, J.; Chen, H.-N.; Chiang, F.-I.; Takemoto, J. Y.; Bensaci, M.; Chang, C.-W. T.
J. Comb. Chem. 2007, 9, 17–19.
1H; OCH2Ph), 4.39 (dd, J = 15.1 Hz and 2.4 Hz, 1H; OCH2C„), 4.21 (dd,
J = 15.1 Hz and 2.4 Hz, 1H; OCH2C„), 4.11 (ddd, J = 10 Hz, 5 Hz and 5 Hz, 1H;
H-1), 3.78–3.74 (m, 1H; H-3) overlapping with 3.72–3.69 (m, 3H; H-2 and H-6),
3.60 (dt, J = 5.7 Hz and 5 Hz, 1H; H-5), 3.47 (dd, J = 10.4 Hz and 8.5 Hz, 1H; H-
4), 2.50–2.46 (m, 2H; CH2CH@), 2.40 (t, J = 2.4 Hz, 1H; C„CH). 13C NMR (CDCl3,
125 MHz): d = 138.5, 138.2, 138.1 (each s, aromatic C), 134.63 (s, CH alkene),
128.4, 128.38, 128.27, 128.0, 127.78, 127.71, 127.64, 127.51 (each s, aromatic
CH), 116.89 (s, CH2 alkene), 82.3, 79.99, 79.92 (3s, CH), 77.80 (s, C„CH), 75.4,
74.2 (2s, OCH2Ph), 73.6 (s, CH), 73.4 (s, OCH2Ph), 73.05 (s, CH2–C„CH), 70.86
(s, CH), 69.14 (s, C-6), 59.89 (s, C„CH), 29.78 (s, CH2CH@). HRMS (ESI): found
535.2460 [M+Na]+, C33H36O5Na requires 535.2460.
8. (a) Rajagopal, R.; Jarikote, D. V.; Srinivasan, K. V. Chem. Commun. 2002, 616–
617; (b) Deshmukh, R. R.; Rajagopal, R.; Srinivasan, K. V. Chem. Commun. 2001,
1544–1545.
Compound 13: 1H NMR (CDCl3, 500 MHz): d = 7.31–7.24 (m, 18H; aromatic H),
7.14–7.12 (m, 2H; aromatic H), 5.44 (q, J = 5.8 Hz, 1H; allenyl CH), 4.94 (d,
J = 10.9 Hz, 1H; OCH2Ph), 4.85–4.83 (m, 2H; allenyl CH2), 4.82–4.81 (m, 1H,
OCH2Ph), 4.8 (d, J = 11.3 Hz, 2H; OCH2Ph), 4.66 (d, J = 3.7 Hz, 2H; OCH2Ph), 4.61
(dd, J = 10.9 Hz and 6.4 Hz, 1H; H-1), 4.48 (dd, J = 3.2 Hz and 1.0 Hz, 2H;
OCH2Ph), 3.83–3.75 (m, overlapping signals 3H, H-3, H-2, overlapping signals
1H; H-5), overlapping signals 3.72–3.68 (m, 1H; H-4) overlapping signals 3.63
(dd, J = 8.5 Hz and 7.5 Hz, 2H; H-6). 13C NMR (CDCl3, 125 MHz): d = 209.4
(allenyl @C@), 138.8, 138.2, 138.19, 138.15 (s, aromatic C), 128.4, 128.37,
128.37, 128.35, 128.33, 127.98, 127.93, 127.78, 127.75, 127.70, 127.6, 127.56
(s, aromatic CH), 85.6 (allenyl CH), 82.6, 79.9 (2s, CH), 78.1 (CH2 allenyl), 75.5,
75.1 (2s, OCH2Ph), 73.5 (s, CH), 72.8, 72.36 (2s, OCH2Ph), 72.0 (s, CH), 68.9 (s, C-
6). HRMS (ESI): found 585.2617 [M+Na]+, C37H38O5Na requires 585.2617.
Compound 15: 1H NMR (CDCl3, 500 MHz): d = 7.36–7.31 (m, 15H; aromatic H),
5.7 (q, J = 5.7 Hz, 1H; allenyl CH), 4.90 (d, J = 10.8 Hz, 1H; OCH2Ph), 4.86–4.83
(m, 2H; allenyl CH2), 4.80 (d, J = 10.7 Hz, 1H; OCH2Ph), 4.72–4.70 (m, 1H;
OCH2Ph), 4.65 (d, J = 4.6 Hz, 2H; OCH2Ph), 4.61 (dd, J = 7.4 Hz and 3.1 Hz, 1H;
H-1), 4.54 (d, J = 8.7 Hz, 1H; OCH2Ph), 4.39 (dd, J = 15.1 Hz and 2.4 Hz, 1H;
OCH2C„), 4.21 (dd, J = 15.1 Hz and 2.3 Hz, 1H; OCH2C„), 3.80–3.70 (m, 5H;
overlapping signals of H-3, H-2, H-5 and H-6), 3.51 (dd, J = 11.6 Hz and
J = 9.7 Hz, 1H; H-4), 2.40 (t, J = 2.3 Hz, 1H; C„CH). 13C NMR (CDCl3, 125 MHz):
d = 209.4 (allenyl @C@), 138.5, 138.1, 137.5 (each s, aromatic C), 128.46,
128.40, 128.38, 128.33, 128.31, 127.29, 128.09, 127.96, 127.94, 127.9, 127.8,
127.76, 127.70, 127.66, 127.56 (each s, aromatic CH), 85.5 (CH), 82.3 (CH2C„),
79.8 (s, CH2), 77.80 ((OCH2C„), 75.5, 74.26, 73.5 (3s, OCH2Ph), 72.8, 72.02, 71.9
(3s, CH), 70.86 (s, CH), 69.08 (s, C-6), 60.00 (s, C„CH), 29.70 (s, CH2CH@). HRMS
(ESI): found 533.2305 [M+Na]+, C33H34O5Na requires 533.2304.
9. (a) Jarikote, D. V.; Murphy, P. V. Eur. J. Org. Chem. (Microreview) 2010, 26, 4959–
4970; (b) Andre, S.; Velasco-Torrijos, T.; Leyden, R.; Gouin, S.; Tosin, M.;
Murphy, P. V.; Gabius, H.-J. Org. Biomol. Chem. 2009, 7, 4715–4725; (c) Leyden,
R.; Velasco-Torrijos, T.; Andre, S.; Gouin, S.; Gabius, H.-J.; Murphy, P. V. J. Org.
Chem. 2009, 74, 9010–9026; (d) Pilgrim, W.; Murphy, P. V. Org. Lett. 2009, 11,
939–942; (e) Murphy, P. V. Eur. J. Org. Chem. 2007, 4177–4187; (f) O’Brien, C.;
Polakova, M.; Pitt, N.; Tosin, M.; Murphy, P. V. Chem. Eur. J. 2007, 13, 902–909.
10. Hung, S.-C.; Lin, C.-C.; Wong, C.-H. Tetrahedron Lett. 1997, 38, 5419–5422.
11. Panek, J. S.; Sparks, M. A. J. Org. Chem. 1989, 54, 2034–2038.
12. To
methyl
2,3,4,6-tetra-O-benzyl-
a-
D
-glucopyranoside
(1)
(100 mg,
0.18 mmol) in dry MeCN (2.0 mL) under N2 at room temperature, allyl
trimethylsilane or propargyltrimethylsilane (0.36 mmol) was added, followed
by dropwise addition of trimethylsilyl triflate (20 mg, 0.09 mmol) before
closing the vessel. The reaction mixture was then sonicated for 15 min, after
which it was quenched with saturated aqueous NaHCO3 (2.0 mL), diluted with
EtOAc (5.0 mL) and washed with brine (3.0 mL). The separated organic extracts
were combined, dried (MgSO4), filtered and the solvent was removed under
reduced pressure to give an oil. Chromatography of the oil (cyclohexane–
EtOAc, 8:1) gave 7 or 13.
13. Analytical data for selected compounds:
Compound 9: 1H NMR (CDCl3, 500 MHz): d = 7.36–7.26 (m, 15H; aromatic H),
5.86–5.77 (m, 1H; alkene CH), 5.13–5.06 (m, 2H; alkene CH2), 4.91 (d,
J = 10.8 Hz, 1H; OCH2Ph), 4.80 (d, J = 10.8 Hz, 1H; OCH2Ph), 4.68 (d, J = 11.6 Hz,
1H; OCH2Ph), 4.70 (dd, J = 11.6 Hz and 2.6 Hz, 2H; OCH2Ph), 4.52 (d, J = 11.9 Hz,